Alignment Healthcare, Inc.
Close on Oct 19, 2026
- Market cap
- $1.81B
- P/E (TTM)
- 49.4
- Dividend yield
- –
Earnings
Next report expected Oct 29, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 30, 2026 | After market close | $1.34B | $0.17 | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 30, 2026 | After market close | $1.24B | $0.05 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | After market close | $1.01B | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 30, 2025 | After market close | $993.70M | $0.02 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 30, 2025 | After market close | $1.02B | $0.07 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 1, 2025 | After market close | $926.90M | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | After market close | $701.20M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 29, 2024 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 1, 2024 | After market close | $681.30M | $-0.13 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 2, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Jul 30, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Three Months Ending September 30, 2026 | $20.00M to $30.00M | New |
| Adjusted Gross Profitnon-GAAP | Three Months Ending September 30, 2026 | $148.00M to $158.00M | New |
| Health Plan Membership | Three Months Ending September 30, 2026 | 295,500 to 297,500 | New |
| Revenue | Three Months Ending September 30, 2026 | $1.30B to $1.32B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Alignment Healthcare filed with the SEC
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Strengthens Leadership Team to
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
1 1 Medicare Advantage Done Right Exhibit 99.2
Regulation FD disclosure · EX-99.2 to Form 8-K
Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Alignment Healthcare Announces Private Convertible Senior Notes Transaction
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Alignment Healthcare Reports Third Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
Alignment Healthcare Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Second Quarter 2023 Results; Beats Outlook Across All Four Critical KPIs
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Strong First Quarter 2023 Results; Exceeds Outlook Across All Four Critical KPIs
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2022 Results; Provides Full-Year 2023 Financial Guidance
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Third Quarter Results; Continues to Beat Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Second Quarter Results; Exceeds Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports First Quarter 2022 Financial Results; Beats Guidance Across Four Key KPIs; Continues Sustainable Growth
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K
Alignment Healthcare Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Alignment Healthcare Reports Third Quarter 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K